Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mov Disord ; 34(6): 821-831, 2019 06.
Article in English | MEDLINE | ID: mdl-31002748

ABSTRACT

BACKGROUND: Prolonged dopaminergic replacement therapy in PD results in pulsatile dopamine receptors stimulation in both dorsal and ventral striatum causing wearing off, motor fluctuations, and nonmotor side effects such as behavioral addictions. Among impulse control disorders, binge eating can be easily modeled in laboratory animals. OBJECTIVES: We hypothesize that manipulation of dopamine levels in a 6-hydroxydopamine-lesioned rats, as a model of PD characterized by a different extent of dopamine denervation between dorsal and ventral striatum, would influence both synaptic plasticity of the nucleus accumbens and binge-like eating behavior. METHODS: Food preference, food intake, and weight gain were monitored in sham-operated and unilaterally lesioned rats, subjected to a modified version of Corwin's limited access protocol, modelling binge eating disorder. Electrophysiological properties and long-term potentiation of GABAergic spiny projection neurons of the nucleus accumbens core were studied through ex vivo intracellular and patch-clamp recordings from corticostriatal slices of naïve and l-dopa-treated rats. RESULTS: Sham-operated animals with intact nucleus accumbens core plasticity reliably developed food-addiction-like behavior when exposed to intermittent access to a highly palatable food. In contrast, parkinsonian rats were unresponsive to such restriction regimens, and also plasticity was lost in ventral spiny neurons. Chronic l-dopa reestablished long-term potentiation and compulsive eating, but with a different temporal dynamic that follows that of drug administration. CONCLUSIONS: Our data indicate that endogenous and exogenous dopamine drive binge-like consumption of a palatable food in healthy and parkinsonian rats with distinct temporal dynamics, providing new insights into the complexity of l-dopa effects on the mesolimbic dopaminergic system. © 2019 International Parkinson and Movement Disorder Society.


Subject(s)
Dopamine Agents/pharmacology , Eating/drug effects , Feeding Behavior/drug effects , Levodopa/pharmacology , Parkinsonian Disorders/physiopathology , Animals , Food Preferences/drug effects , Long-Term Potentiation/drug effects , Male , Nucleus Accumbens/drug effects , Nucleus Accumbens/physiopathology , Oxidopamine , Parkinsonian Disorders/chemically induced , Rats , Rats, Wistar , Weight Gain/drug effects
2.
EFSA J ; 16(8): e05378, 2018 Aug.
Article in English | MEDLINE | ID: mdl-32626021

ABSTRACT

The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, Italy, for the pesticide active substance florpyrauxifen-benzyl are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative use of florpyrauxifen-benzyl as an herbicide on rice. The reliable endpoints, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.

3.
Mov Disord ; 32(7): 1035-1046, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28394013

ABSTRACT

BACKGROUND: Recent studies support the therapeutic utility of repetitive transcranial magnetic stimulation in Parkinson's disease (PD), whose progression is correlated with loss of corticostriatal long-term potentiation and long-term depression. Glial cell activation is also a feature of PD that is gaining increasing attention in the field because astrocytes play a role in chronic neuroinflammatory responses but are also able to manage dopamine (DA) levels. METHODS: Intermittent theta-burst stimulation protocol was applied to study the effect of therapeutic neuromodulation on striatal DA levels measured by means of in vivo microdialysis in 6-hydroxydopamine-hemilesioned rats. Effects on corticostriatal synaptic plasticity were studied through in vitro intracellular and whole-cell patch clamp recordings while stepping test and CatWalk were used to test motor behavior. Immunohistochemical analyses were performed to analyze morphological changes in neurons and glial cells. RESULTS: Acute theta-burst stimulation induced an increase in striatal DA levels in hemiparkinsonian rats, 80 minutes post-treatment, correlated with full recovery of plasticity and amelioration of motor performances. With the same timing, immediate early gene activation was restricted to striatal spiny neurons. Intense astrocytic and microglial responses were also significantly reduced 80 minutes following theta-burst stimulation. CONCLUSION: Taken together, these results provide a first glimpse on physiological adaptations that occur in the parkinsonian striatum following intermittent theta-burst stimulation and may help to disclose the real potential of this technique in treating PD and preventing DA replacement therapy-associated disturbances. © 2017 International Parkinson and Movement Disorder Society.


Subject(s)
Astrocytes/physiology , Cerebral Cortex , Corpus Striatum , Dopamine/metabolism , Microglia/physiology , Motor Activity/physiology , Neuronal Plasticity/physiology , Parkinsonian Disorders/therapy , Transcranial Magnetic Stimulation/methods , Adrenergic Agents/pharmacology , Animals , Behavior, Animal/physiology , Cerebral Cortex/metabolism , Cerebral Cortex/physiopathology , Corpus Striatum/metabolism , Corpus Striatum/physiopathology , Genes, Immediate-Early/physiology , Male , Microdialysis , Oxidopamine/pharmacology , Parkinsonian Disorders/chemically induced , Patch-Clamp Techniques , Rats , Rats, Wistar , Theta Rhythm/physiology
4.
Neuropharmacology ; 101: 341-50, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26471421

ABSTRACT

Memantine is an open channel blocker that antagonizes NMDA receptors reducing the inappropriate calcium (Ca(2+)) influx occurring in presence of moderately increased glutamate levels. At the same time, memantine has the ability to preserve the transient physiological activation of NMDA receptor, essential for learning and memory formation at synaptic level. In the present study we investigated the effects exerted by memantine on striatal synaptic plasticity in rat striatal spiny projection neurons (SPNs). In vitro application of memantine in striatal slices elicited a disruption of long-term potentiation (LTP) induction and maintenance, and revealed, in the majority of the recorded neurons, a long-term depression (LTD), whose amplitude was concentration-dependent (0.3-10 µM). Interestingly, preincubation with the dopamine (DA) D2 receptor antagonist sulpiride (10 µM) prevented memantine-induced LTD and restored LTP. Moreover, the DA D2 agonist quinpirole (10 µM), similarly to memantine, induced LTD in a subgroup of SPNs. In addition, memantine-induced LTD was also prevented by the CB1 endocannabinoid receptor antagonist AM 251 (1 µM). These results suggest that the actions exerted by memantine on striatal synaptic plasticity, and in particular the induction of LTD observed in SPNs, could be attributed to its ability to activate DA D2 receptors. By contrast, blockade of NMDA receptor is not involved in memantine-induced LTD since APV (30 µM) and MK801 (10 µM), two NMDA receptor antagonists, failed to induce this form of synaptic plasticity. Our data indicate that memantine could be used as treatment of neurological disorders in which DA D2 receptor represents a possible therapeutic target.


Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Long-Term Potentiation/drug effects , Memantine/pharmacology , Synapses/drug effects , Analysis of Variance , Animals , Biophysics , Central Nervous System Stimulants/pharmacology , Cerebral Cortex/drug effects , Corpus Striatum/drug effects , Dose-Response Relationship, Drug , Electric Stimulation , In Vitro Techniques , Male , Patch-Clamp Techniques , Picrotoxin/pharmacology , Rats , Rats, Wistar , Time Factors
5.
Neurobiol Dis ; 86: 140-53, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26639853

ABSTRACT

L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias (LIDs) represent the main side effect of Parkinson's Disease (PD) therapy. Among the various pharmacological targets for novel therapeutic approaches, the serotonergic system represents a promising one. In experimental models of PD and in PD patients the development of abnormal involuntary movements (AIMs) and LIDs, respectively, is accompanied by the impairment of bidirectional synaptic plasticity in key structures such as striatum. Recently, it has been shown that the 5-HT1A/1B receptor agonist, eltoprazine, significantly decreased LIDs in experimental PD and human patients. Despite the fact that several papers have tested this and other serotonergic drugs, nothing is known about the electrophysiological consequences on this combined serotonin receptors modulation at striatal neurons. The present study demonstrates that activation of 5-HT1A/1B receptors reduces AIMs via the restoration of Long-Term Potentiation (LTP) and synaptic depotentiation in a sub-set of striatal spiny projection neurons (SPNs). This recovery is associated with the normalization of D1 receptor-dependent cAMP/PKA and ERK/mTORC signaling pathways, and the recovery of NMDA receptor subunits balance, indicating these events as key elements in AIMs induction. Moreover, we analyzed whether the manipulation of the serotonergic system might affect motor behavior and cognitive performances. We found that a defect in locomotor activity in parkinsonian and L-DOPA-treated rats was reversed by eltoprazine treatment. Conversely, the impairment in the striatal-dependent learning was found exacerbated in L-DOPA-treated rats and eltoprazine failed to recover it.


Subject(s)
Behavior, Animal/drug effects , Corpus Striatum/drug effects , Corpus Striatum/physiopathology , Dyskinesia, Drug-Induced/physiopathology , Neurons/drug effects , Neurons/physiology , Parkinsonian Disorders/complications , Piperazines/administration & dosage , Serotonin Receptor Agonists/administration & dosage , Animals , Corpus Striatum/metabolism , Dyskinesia, Drug-Induced/metabolism , Dyskinesia, Drug-Induced/psychology , Levodopa , MAP Kinase Signaling System/drug effects , Male , Motor Activity/drug effects , Neuronal Plasticity/drug effects , Neurons/metabolism , Oxidopamine , Parkinsonian Disorders/chemically induced , Rats , Rats, Wistar , Synapses/metabolism , Synaptic Transmission/drug effects , TOR Serine-Threonine Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...